Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF | Roche | Completed | Tocilizumab | 3 | ML22726 | KFSH |
| THydroxychloroquine versus Standard of Care for the Management of COVID-19 | King Abdulaziz University Hospital | Completed | Hydroxychloroquine sulphate | 3 | 249-20 | KAUH-J |
| Therapeutic Effects of Colchicine in the Treatment of Symptomatic and Acute Respiratory Distress Syndrome in COVID-19 Patients | KACST | Completed | Colchicine | 3 | 5200107 | DCH |
| The study of efficacy and saftey of Rituximab in treatment of resistant glomerulonephritis | The Saudi center for Organ Transplantation (SCOT) | Completed | Rituximab | 3 | MN-101-11 | KFMC |
| "The efficacy of Leukotriene Inhibitor in Adult Patients with mild and moderate SARSCOV- 2 symptoms (COVID19): (Randomized Clinical Trial)" | KAIMRC | Ongoing | Zafirlukast | 2 | RC20/206/R | King Abdulaziz Medical City NG (Riyadh) |
| The Efficacy of an anti-inflammatory/antioxidant oral nutrition Supplementation on the Progression of COVID-19 in SARS-CoV-2 positive cases: A Randomized Controlled Trial | General Directorate of Research and Studies, Ministry of Health | Ongoing | Dietary Supplement containing Vitamins A, C, E, selenium and Zinc | 3 | 20092202 | Prince Mohammad bin Abdulaziz hospital (Riyadh) |
| The Efficacy and Safety of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias | ApoPharma Inc. | Ongoing | " Deferiprone Deferoxamine" | 3b | LA38-0411 | ACH |
| "The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension." | Allergan | Ongoing | Bimatoprost SR | 3 | 192024-092 | KKESH |
| The Effectiveness of Convalescent Plasma Transfusion in Preventing Clinical Deterioration and Critical Care Admission in COVID 19 Patients at a Primary Corona Centre in Riyadh, Saudi Arabia | PMBAH | Ongoing | Convalescent Plasma | 2 | 20-252C | Prince Mohammad bin Abdulaziz hospital (Riyadh) |
| The Effectiveness of Convalescent Plasma for the Treatment of Severe COVID-19 Cases in Intensive Care Unit | King Faisal Specialist Hospital and Research Centre | Ongoing | Convalescent Plasma | 3 | IRB 2020-19-V2 | KFSH&RC-J |